Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection

No abstract is available for this paper.

• Publication year

  1996

• Venue

  British Journal of Nutrition

• Publication date

  1996-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1079/BJN19960116PMID 8785183
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anabolic Steroids in Athletics : Crossover Double-blind Trial on Weightlifters

  2006cited by this paper
• Effects of megestrol acetate therapy on body composition and circulating testosterone concentrations in patients with AIDS.

  1995cited by this paper
• Megestrol Acetate in Patients with AIDS and Cachexia

  1994cited by this paper
• Megestrol Acetate in Patients with AIDS-related Cachexia

  1994cited by this paper
• Endocrine function in the HIV wasting syndrome.

  1994cited by this paper
• Megestrol acetate in patients with AIDS-related cachexia.

  1994cited by this paper
• Ketotifen Inhibits Tumor Necrosis Factor α Production in the Peripheral Blood Mononuclear Cells of Patients Infected with Human Immunodeficiency Virus

  1994cited by this paper
• Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection.

  1993cited by this paper
• Body-composition changes in patients who gain weight while receiving megestrol acetate.

  1993cited by this paper
• Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection.

  1993cited by this paper
• Effect of Dronabinol on Nutritional Status in HIV Infection

  1993cited by this paper
• Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex.

  1993cited by this paper
• Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes.

  1993cited by this paper
• Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.

  1993cited by this paper
• Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped.

  1992cited by this paper
• Effect of testosterone on metabolic rate and body composition in normal men and men with muscular dystrophy.

  1992cited by this paper
• Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.

  1992cited by this paper
• Effect of megestrol acetate on the human pituitary-adrenal axis.

  1992cited by this paper
• Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.

  1992cited by this paper
• Plasma viraemia as a marker of viral replication in HIV-infected individuals.

  1991cited by this paper
• The metabolic effects of tumor necrosis factor and other cytokines

  1991cited by this paper
• Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage.

  1991cited by this paper
• The role of body protein studies in clinical trials.

  1990cited by this paper
• In Vivo Body Composition Studies

  1990cited by this paper
• Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy.

  1989cited by this paper
• Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS.

  1989cited by this paper
• Body mass repletion during ganciclovir treatment of cytomegalovirus infections in patients with acquired immunodeficiency syndrome.

  1989cited by this paper
• AIDS dementia complex.

  1988cited by this paper
• Oxymetholone Therapy in Patients with Familial Antithrombin III Deficiency

  1988cited by this paper
• Endocrine disorders in men infected with human immunodeficiency virus.

  1988cited by this paper
• Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.

  1988cited by this paper
• Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations.

  1988cited by this paper
• The AIDS dementia complex: I. Clinical features

  1986cited by this paper
• Severe hyperglucagonaemia during treatment with oxymetholone.

  1986cited by this paper
• A data-based approach to diet questionnaire design and testing.

  1986cited by this paper
• Correlations of body mass indices with weight, stature, and body composition in men and women in NHANES I and II.

  1986cited by this paper
• Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.

  1986cited by this paper
• The effect of anabolic steroids on lean body mass: the dose response curve.

  1985cited by this paper
• The Karnofsky performance status scale: An examination of its reliability and validity in a research setting

  1984cited by this paper
• Hepatic lesions in patients on anabolic androgenic therapy.

  1983cited by this paper
• Nutrition, immunity, and infection: present knowledge and future directions.

  1983cited by this paper
• Anabolic Steroids.

  1983cited by this paper
• Carcinoma of trachea following iodine-125 therapy for thyrotoxicosis.

  1982cited by this paper
• Effects of methandienone on the performance and body composition of men undergoing athletic training.

  1981cited by this paper
• Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

  1981cited by this paper
• Single-nutrient effects on immunologic functions. Report of a workshop sponsored by the Department of Food and Nutrition and its nutrition advisory group of the American Medical Association.

  1981cited by this paper
• Anabolic-Androgenic Steroids

  1976cited by this paper
• Regulation of Protein Synthesis by Anabolic-Androgenic Steroids

  1976cited by this paper
• Interaction of anabolic steroids with glucocorticoid receptor sites in rat muscle cytosol.

  1975cited by this paper
• Protein-calorie malnutrition. A host determinant for Pneumocystis carinii infection.

  1974cited by this paper
• Evaluation of the protein anabolic properties of certain orally active anabolic agents based on nitrogen balance studies in rats.

  1963cited by this paper
• Anabolic steroids.

  1960cited by this paper
• Handbook of Physiology.

  1960cited by this paper

• A Triad of Physical Masculinities: Examining Multiple ‘Hegemonic’ Bodybuilding Identities in Anabolic-Androgenic Steroid (AAS) Online Discussion Groups

  2023cites this paper
• Therapeutic effects of androgens for cachexia.

  2021cites this paper
• Profiling of anabolic androgenic steroids and selective androgen receptor modulators for interference with adrenal steroidogenesis.

  2019cites this paper
• SOME AROMATIC AMINES AND RELATED COMPOUNDS VOLUME 127 IARC MONOGRAPHS ON THE IDENTIFICATION OF CARCINOGENIC HAZARDS TO HUMANS

  2019cites this paper
• Hepatotoxicity Associated with Methylstenbolone and Stanozolol Abuse

  2018cites this paper
• Hepatotoxicity Associated with Nutritional Supplements Containing Anabolic Steroids

  2018cites this paper
• Les suppléments utilisés en musculation pour améliorer la condition physique

  2017cites this paper
• Extracellular polysaccharides purified from Aureobasidium pullulans SM-2001 (Polycan) inhibit dexamethasone-induced muscle atrophy in mice

  2017cites this paper
• The administration of Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy in mice

  2015cites this paper
• Palliative Pharmacotherapy: State-of-the-Art Management of Symptoms in Patients With Cancer.

  2015cites this paper
• Clinical Update on Nursing Home Medicine: 2015.

  2015cites this paper
• Impact of caffeine on weight changes due to ketotifen administration.

  2014cites this paper
• Characterization of the muscle proteome in cancer cachexia: Identification of novel targets for intervention

  2013cites this paper
• Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients.

  2013cites this paper
• Preconcentration and spectrophotometric determination of oxymetholone in the presence of its main metabolite (mestanolone) using modified maghemite nanoparticles in urine sample.

  2013cites this paper
• Identifying a Treatment Blood Pressure Target for Frail Elders The Systolic Hypertension in the Elderly Program

  2013cites this paper
• Oxidative Stress, Dietary Antioxidant Supplements, and Health: Is the Glass Half Full or Half Empty?

  2013cites this paper
• Clinical update on nursing home medicine: 2013.

  2013cites this paper
• EFFECTS OF OXYMETHOLONE ON ESTROGEN AND PROGESTERONE HORMONE LEVELS AND BODY WEIGHT IN IMMATURE FEMALE RATS FROM NEONATAL MICE TREATED MOTHERS DURING PREGNANCY AND LACTATION

  2013cites this paper
• Glukokortikoide und Androgene zur Behandlung von Müdigkeit und Schwäche bei Palliativpatienten

  2012cites this paper
• [Glucocorticoids and androgens for treatment of tiredness and weakness in palliative care patients : a systematic review].

  2012cites this paper
• LOS ESTEROIDES ANABOLIZANTES ANDROGÉNICOS, RIESGOS Y CONSECUENCIAS ANABOLIC ANDROGENIC STEROIDS, RISKS AND CONSEQUENCES

  2012cites this paper
• Anabolic androgenic steroids abuse and liver toxicity.

  2011cites this paper
• Use of orexigenic medications in geriatric patients.

  2011cites this paper
• Anabolic Steroids: Metabolism, Doping and Detection in Human and Equestrian Sports

  2010cites this paper
• Position Stand on Androgen and Human Growth Hormone Use

  2009cites this paper
• NUTRACÈUTICS: IMPLICACIÓ TERAPÈUTICA EN CAQUÈXIA CANCEROSA I DIABETIS

  2009cites this paper
• Drug-Induced Changes to Nutritional Status

  2009cites this paper
• Long-term effects of oxymetholone vs. Testosterone with or without ZnSO4 on growth performance of turkey chicks.

  2009influential citation
• Clinical update on nursing home medicine: 2009.

  2009cites this paper
• Anorexia

  2009cites this paper
• Chemometric and chemoinformatic analyses of anabolic and androgenic activities of testosterone and dihydrotestosterone analogues.

  2008cites this paper
• Updates from the AMDA Meeting Clinical Update on Nursing Home Medicine: 2013

  2008cites this paper
• Unintended weight loss in older persons

  2008cites this paper
• Anabolic Steroid Use

  2008cites this paper
• Hepatotoxicity associated with dietary supplements containing anabolic steroids.

  2007cites this paper
• Management of Protein-Energy Undernutrition in Older Adults

  2007cites this paper
• Guidelines for the use of orexigenic drugs in long-term care.

  2006cites this paper
• A novel in‐silico approach for QSAR Studies of Anabolic and Androgenic Activities in the 17β‐hydroxy‐5α‐androstane Steroid Family

  2005cites this paper
• Weight Loss in Older Adults

  2005cites this paper
• Anabolic steroids for the treatment of weight loss in HIV-infected individuals.

  2005cites this paper
• A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.

  2005cites this paper
• Hypogonadism in Men With HIV-AIDS

  2004cites this paper
• Increased body weight and improved quality of life in AIDS patients following V-1 Immunitor administration

  2004cites this paper
• Weight Gain, Improvements in Metabolic Profiles and Immunogenicity with Insulin or Sulphonylurea Administration in AIDS

  2004cites this paper
• The pharmacological treatment of cachexia.

  2004cites this paper
• L'altération des fonctions sensorielles et de l'appétit est-elle une fatalité chez le sujet âgé ?

  2004cites this paper
• Male Hypogonadism

  2004cites this paper
• The Association between Nutrient Intake, Body Anthropometry and Quality of Life of HIV/AIDS Patients in Ghana

  2003influential citation
• Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.

  2003cites this paper
• Androgen Administration in Sarcopenia Associated with Chronic Illness

  2003cites this paper
• HIV and testosterone therapy.

  2003cites this paper
• Weight loss and wasting in patients infected with human immunodeficiency virus.

  2003cites this paper
• Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting

  2003cites this paper
• Testosterone replacement for hypogonadism: clinical findings and best practices.

  2003cites this paper
• Anabolic steroids in sport: biochemical, clinical and analytical perspectives

  2003cites this paper
• Heated amphotericin to treat leishmaniasis.

  2003cites this paper
• Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting.

  2002cites this paper
• Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis.

  2002cites this paper
• Validation of the determination of oxymetholone in human plasma analysis using gas chromatography-mass spectrometry. Application to pharmacokinetic studies.

  2002cites this paper
• Prevención y tratamiento de la desnutrición en niños con VIH

  2002cites this paper
• Changes in lean body mass and total body weight are weakly associated with physical functioning in patients with HIV infection

  2002cites this paper
• Neuroendocrine abnormalities associated with HIV infection.

  2001cites this paper
• The use of anabolic agents in HIV disease

  2001cites this paper
• Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases.

  2001cites this paper
• Review of oxymetholone: A 17α-alkylated anabolic-androgenic steroid

  2001cites this paper
• Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid.

  2001cites this paper
• A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids.

  2001cites this paper
• The Measurement of Health-Related Quality of Life in Prospective Drug Therapy Studies in HIV-Infected Patients

  2001cites this paper
• Cancer cachexia: A therapeutic approach

  2001cites this paper
• Acute and Long‐Term Effects of AIDS and Injection Drug Use on Gonadal Function

  2000cites this paper
• Weight Gain, Improvement in Metabolic Profile, and CD4 Count with Insulin Administration in an AIDS Patient

  2000cites this paper
• Relation of Lean Body Mass to Health‐Related Quality of Life in Persons With HIV

  2000cites this paper
• Cachexia and anorexia: cancer's covert killer

  2000cites this paper
• Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.

  2000cites this paper
• Treatment guidelines for HIV-associated wasting.

  2000cites this paper
• Nutrition in the Care of the Cancer Patient

  2000cites this paper
• Hormones as Performance-Enhancing Drugs

  2000cites this paper
• Androgen Deficiency in Men Without Overt Pituitary-Gonadal Disease: The Role of Testosterone Therapy

  2000cites this paper
• Dialysis in Patients with Human Immunodeficiency Virus Infection

  2000cites this paper
• Cachexia and asthenia in cancer patients.

  2000cites this paper
• Relation of lean body mass to health-related quality of life in persons with HIV.

  2000cites this paper
• Potential Interventions for HIV/AIDS Wasting: An Overview

  2000cites this paper
• Cognitive-behavioral stress management increases free testosterone and decreases psychological distress in HIV-seropositive men.

  2000cites this paper
• Use of growth hormone and other anabolic agents in AIDS wasting.

  1999cites this paper
• The use of an anabolic steroid (nandrolone decanoate) to improve nutritional status after esophageal resection for carcinoma.

  1999cites this paper
• Oxymetholone: I. Evaluation in a Comprehensive Battery of Genetic Toxicology and In Vitro Transformation Assays

  1999cites this paper
• Increased Soft Tissue in the Posterior Cervical and Upper Back Area of Patients on HIV-1 Protease Inhibitors

  1999cites this paper
• Anabolic steroids.

  1999cites this paper
• Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection?

  1999cites this paper
• Applications of Androgen Therapy for Muscle Wasting Associated with Human Immunodeficiency Virus-Infection and Other Chronic Diseases

  1999cites this paper
• Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.

  1998cites this paper
• Steroids as possible inhibitors of HIV-1 protease.

  1998cites this paper
• Human immunodeficiency virus-associated wasting and mechanisms of cachexia associated with inflammation.

  1998cites this paper
• Androgen therapy in AIDS wasting.

  1998cites this paper
• Low dihydrotestosterone and weight loss in the AIDS wasting syndrome.

  1998cites this paper
• The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women.

  1998cites this paper
• Single-agent/combination therapy of human immunodeficiency virus-related wasting.

  1998cites this paper
• Androgen therapy in non-gonadal disease

  1998cites this paper
• A Review of the Drug Treatment of Cachexia Associated with Cancer

  1998cites this paper